- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05596604
"Awareness, Preconception, and Fear of Epidural Analgesia Among Childbearing Women in Saudi Arabia."
October 24, 2022 updated by: Abdulrhman Alshihri, King Khalid University Hospital
The aim of our study is to measure the level of awareness, preconceptions, and level of fear regarding epidural analgesia among childbearing women in KKUH in Riyadh.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This research was designed as a hospital-based observational cross-sectional study conducted at King Khalid University Hospital, using a self-administered questionnaire based on previous research.22-24-26
approved by the Institutional Review Board at King Saud University, College of Medicine, Riyadh, Saudi Arabia on 08.August.2022
Ref. No. 22/0592/IRB.
The sample included pregnant women attending an obstetrical clinic for routine antenatal follow-up, and the data collection was conducted during the month of August 2022.
The questionnaire included five parts (sociodemographic, preconception, awareness, fear, and desirability).
a total of 26 questions with multiple-choice answers.
The sample size was determined using the Comrey and Lee criterion Comrey and Lee (1992) stated that a 200-sample size is acceptable.
The questionnaire was completed by 202 participants who met the inclusion criteria that is being a pregnant woman and completing the survey, and the exclusion criteria were non-pregnant women and an incomplete survey.
The data collectors made it clear to the participants that taking part in the study was completely optional, and the participants signed anonymous consent forms.
Study Type
Observational
Enrollment (Actual)
202
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Riyadh, Saudi Arabia
- King Khalid Medical City
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 55 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
included pregnant women attending an obstetrical clinic for routine antenatal follow-up
Description
Inclusion Criteria:
- pregnant woman
- completing the survey
Exclusion Criteria:
- non-pregnant women
- incomplete survey
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Awareness
Time Frame: month
|
assess awareness among participants
|
month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2022
Primary Completion (Actual)
August 29, 2022
Study Completion (Actual)
October 10, 2022
Study Registration Dates
First Submitted
October 24, 2022
First Submitted That Met QC Criteria
October 24, 2022
First Posted (Actual)
October 27, 2022
Study Record Updates
Last Update Posted (Actual)
October 27, 2022
Last Update Submitted That Met QC Criteria
October 24, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 4361020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
we are not planning to share data
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Assess Women Awareness and Fear About EDA for Labor
-
University of PennsylvaniaCompletedWomen Admitted to Labor and Delivery for the Management of Preterm Labor and/or Preterm Premature Rupture of Membranes (PPROM)United States
Clinical Trials on survey- no intervention
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
Centre Hospitalier de CayenneCompleted
-
Centre Hospitalier de CayenneCompleted
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Wake Forest University Health SciencesCompletedCardiovascular Diseases | ST Elevation Myocardial InfarctionUnited States
-
Rutgers, The State University of New JerseyTerminated
-
University of BernCompletedPTSD | Trauma | Suicidal Ideation | Self Efficacy | Coping SkillsSwitzerland
-
Central Hospital, Nancy, FranceUnknownMelanoma | Skin Cancer | Oncology | Skin Squamous Cell Carcinoma | Advance Directives | Skin Lymphoma | Metastatic Basal Cell CarcinomaFrance
-
Global Foundation for the Care of Newborn InfantsNot yet recruitingStress, Psychological | Anxiety | Caregiver Burden | Parents | Emotions | Fear | Uncertainty | Infant, Premature | Infant, Low Birth Weight | Life Change Events | Needs AssessmentGermany